Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Current Value
$16.891 Year Return
Current Value
$16.891 Year Return
Market Cap
$19.05B
P/E Ratio
-19.76
1Y Stock Return
81.34%
1Y Revenue Growth
9.85%
Dividend Yield
0.00%
Price to Book
3.1
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ASC | 39.12% | $517.16M | -7.62% | 8.45% |
LPX | 38.21% | $7.84B | +85.45% | 0.70% |
HASI | 37.37% | $3.29B | +16.65% | 5.90% |
CRCT | 37.19% | $1.12B | -19.90% | 1.91% |
ELAN | 36.63% | $6.58B | +12.99% | 0.00% |
AMRC | 34.57% | $1.39B | -4.40% | 0.00% |
SMG | 32.54% | $4.24B | +35.01% | 3.52% |
GMED | 30.55% | $11.35B | +81.49% | 0.00% |
CGBD | 30.30% | - | - | 9.47% |
BHE | 30.04% | $1.70B | +86.81% | 1.41% |
BLDP | 29.95% | $398.23M | -61.89% | 0.00% |
LNC | 29.92% | $5.82B | +45.21% | 5.25% |
HY | 29.47% | $948.82M | +15.25% | 2.47% |
XPRO | 29.37% | $1.51B | -16.97% | 0.00% |
MRC | 28.95% | $1.13B | +25.09% | 0.00% |
AEIS | 28.80% | $4.20B | +16.90% | 0.27% |
MKSI | 28.76% | $7.29B | +42.89% | 0.82% |
CHPT | 28.58% | $487.69M | -42.64% | 0.00% |
SEDG | 28.52% | $606.45M | -86.74% | 0.00% |
PRGO | 28.51% | $3.72B | -9.95% | 4.04% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TDY | -0.03% | $21.66B | +18.31% | 0.00% |
MCK | 0.03% | $78.15B | +35.51% | 0.42% |
TNET | -0.07% | $4.41B | -19.81% | 0.84% |
AON | -0.07% | $82.00B | +16.33% | 0.70% |
FCN | -0.11% | $7.10B | -10.74% | 0.00% |
IHG | -0.18% | $19.32B | +55.71% | 1.30% |
GNE | 0.25% | $425.67M | -37.42% | 1.92% |
ODP | -0.26% | $777.35M | -46.62% | 0.00% |
RNR | -0.26% | $13.74B | +23.09% | 0.58% |
PG | 0.28% | $402.15B | +14.14% | 2.33% |
MCD | 0.36% | $208.34B | +3.66% | 2.30% |
BMY | 0.41% | $118.10B | +20.11% | 4.09% |
LNG | 0.45% | $49.37B | +24.99% | 0.82% |
NABL | 0.48% | $1.88B | -14.67% | 0.00% |
BCAN | -0.49% | $72.87M | -99.75% | 0.00% |
WRB | 0.57% | $22.94B | +29.98% | 0.69% |
AVTR | 0.57% | $13.42B | -0.40% | 0.00% |
TXNM | -0.59% | $4.32B | +14.17% | 3.24% |
AMT | -0.62% | $94.00B | +1.83% | 3.29% |
SMC | -0.66% | $383.35M | +97.26% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GO | -24.73% | $1.81B | -34.42% | 0.00% |
DV | -24.36% | $3.26B | -37.48% | 0.00% |
TMCI | -21.95% | $483.43M | -8.71% | 0.00% |
LZ | -20.04% | $1.30B | -33.57% | 0.00% |
LMT | -17.31% | $126.40B | +18.99% | 2.36% |
QLYS | -16.56% | $5.18B | -21.75% | 0.00% |
INSP | -15.75% | $5.28B | +27.64% | 0.00% |
HUSA | -15.38% | $16.69M | -11.56% | 0.00% |
NOC | -14.86% | $71.54B | +4.23% | 1.60% |
HUBS | -14.28% | $35.23B | +44.73% | 0.00% |
ZI | -14.00% | $3.40B | -28.47% | 0.00% |
VRSK | -13.01% | $39.77B | +17.45% | 0.53% |
SEG | -12.18% | $319.72M | +12.41% | 0.00% |
CSTE | -11.60% | $134.01M | +2.92% | 0.00% |
TCTM | -11.24% | $8.10M | -42.99% | 0.00% |
WHLM | -11.17% | $17.64M | -29.34% | 0.00% |
MASI | -10.95% | $8.75B | +73.22% | 0.00% |
TRIP | -10.91% | $1.87B | -29.46% | 0.00% |
RPD | -10.76% | $2.47B | -24.37% | 0.00% |
UNH | -9.65% | $531.00B | +6.93% | 1.37% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 39.80% | $592.06M | 0.36% |
RSPA | 36.57% | $273.87M | 0% |
EFAA | 36.18% | $117.38M | 0% |
QQA | 36.03% | $135.01M | 0% |
ISRA | 35.30% | $79.78M | 0.59% |
IQDF | 33.63% | $592.77M | 0.47% |
DFAX | 33.56% | $7.02B | 0.28% |
VIDI | 33.54% | $340.15M | 0.61% |
IHE | 33.44% | $596.23M | 0.39% |
CGGO | 32.89% | $4.67B | 0.47% |
VEU | 32.60% | $39.04B | 0.07% |
DFSI | 32.59% | $523.15M | 0.24% |
BBIN | 32.48% | $4.77B | 0.07% |
CWI | 32.45% | $1.57B | 0.3% |
ACWX | 32.41% | $4.47B | 0.34% |
HFXI | 32.33% | $796.77M | 0.2% |
ACWI | 32.13% | $19.22B | 0.32% |
DBEU | 32.11% | $540.63M | 0.45% |
EIS | 32.07% | $163.73M | 0.59% |
FTHI | 32.06% | $1.01B | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ICSH | -0.05% | $5.57B | 0.08% |
HYD | 0.05% | $3.18B | 0.32% |
DBO | -0.20% | $217.57M | 0.77% |
UTWO | 0.24% | $447.63M | 0.15% |
VGSH | -0.51% | $19.14B | 0.04% |
WEAT | 0.71% | $120.27M | 0.28% |
CSHI | 0.95% | $482.85M | 0.38% |
FLDR | -0.99% | $595.01M | 0.15% |
SHY | 1.02% | $22.43B | 0.15% |
FTSM | -1.07% | $6.08B | 0.45% |
AGGY | 1.07% | $926.64M | 0.12% |
SCHO | 1.25% | $11.10B | 0.03% |
SGOV | -1.31% | $27.53B | 0.09% |
KMLM | -1.41% | $353.87M | 0.9% |
VUSB | 1.43% | $4.64B | 0.1% |
UNG | 1.43% | $908.80M | 1.06% |
CANE | -1.45% | $17.72M | 0.29% |
TOTL | 1.46% | $3.31B | 0.55% |
SOYB | 1.48% | $27.32M | 0.22% |
SPTS | -1.50% | $5.71B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -19.80% | $388.04M | 1.43% |
USDU | -19.60% | $201.97M | 0.5% |
VIXY | -19.56% | $195.31M | 0.85% |
UUP | -18.93% | $309.25M | 0.77% |
MINT | -13.03% | $11.62B | 0.35% |
XBIL | -12.38% | $637.70M | 0.15% |
IBDP | -12.11% | $2.11B | 0.1% |
BOXX | -11.06% | $4.43B | 0.1949% |
DUSB | -10.15% | $797.63M | 0.15% |
TAIL | -9.77% | $67.98M | 0.59% |
EQLS | -9.31% | $76.08M | 1% |
CORN | -8.86% | $61.12M | 0.2% |
IBTE | -8.80% | $1.70B | 0.07% |
BSCO | -8.64% | $2.35B | 0.1% |
DBA | -7.74% | $755.88M | 0.93% |
CTA | -7.59% | $350.27M | 0.78% |
SHV | -7.56% | $18.13B | 0.15% |
BILZ | -7.51% | $563.02M | 0.14% |
XONE | -7.45% | $548.88M | 0.03% |
TBIL | -7.38% | $4.38B | 0.15% |
Yahoo
We recently published a list of 12 Best Stocks Under $25 To Invest In Right Now. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other best stocks under $25 to invest in right now. A View of the US Stock Market Post-Election As reported […]
SeekingAlpha
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Jefferies London Healthcare Conference November 19, 2024 3:30 AM ETCompany ParticipantsRichard Francis -...
Yahoo
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $17.11 as of Nov 12th. TEVA’s trailing and forward P/E were 872 and 6.26 respectively according to Yahoo […]
Yahoo
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024. The presentation will begin at 8:30 A.M. Greenwich Mean Time (3.30 A.M. Eastern Time). To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archiv
SeekingAlpha
Viatris is poised for appreciation with new product launches and a stronger balance sheet. Read why VTRS stock is a buy due to strong growth and low valuation.
SeekingAlpha
Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its stock promising. Click for my NBIX update.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.